Session Information

  • WCLC 2022

    2022 World Conference on Lung Cancer

    Conference Program for 2022 the World Conference on Lung Cancer

    Presentation Date(s):  
    • August 6 - 9, 2022
    • Total Presentations: 2137

    All times listed are in Vienna, Austria Time, CEST (UTC+2:00)

    PL - Plenary
    IBS - Interactive Breakfast Session (in-person attendees only)
    ES - Education Session
    OA - Oral Session
    MA - Mini Oral Session
    P - Posters
    EP - ePosters
    WS - Workshops
    LA – Lectureship Awards
    IS - Industry Symposium

Filter Results:

Show Only CME Accredited Sessions

  • +

    WS01 - IASLC Reviewer Workshop (By Invitation Only)

    • 09:00 - 15:20
    • 8/05/2022
    • Location: Lehar 1
    • Not for CME Credit
    • Type: Workshop
    • Track: N/A
    • +

      WS01.04 - Abstract, Introduction

      09:40 - 09:55  |  Presenter: ENRIQUETA FELIP

      • Abstract

      Loading...

    • +

      WS01.16 - Article 1 Summary + Group Discussion

      14:30 - 15:00  |  Presenter: ENRIQUETA FELIP

      • Abstract

      Loading...

  • +

    IS05 - Industry Symposium Sponsored by Merck Kgaa Darmstadt: Decisive Moments in the Treatment of MET exon 14 Skipping NSCLC

    • 13:15 - 14:15
    • 8/06/2022
    • Location: Hall C7
    • Not for CME Credit
    • Type: Industry Symposium
    • Track: N/A
    • +

      IS05.04 - Seize the Moment: The Benefits of Early Treatment

      13:40 - 13:55  |  Presenter: ENRIQUETA FELIP

      • Abstract

      Loading...

    • +

      IS05.05 - Make Every Moment Matter: Optimising Treatment

      13:55 - 14:10  |  Presenter: ENRIQUETA FELIP

      • Abstract

      Loading...

  • +

    OA03 - Molecular Targeted Treatments

    • 14:30 - 15:40
    • 8/07/2022
    • Location: Hall C7
    • Not for CME Credit
    • Type: Oral
    • Track: Metastatic Non-small Cell Lung Cancer - Molecular Targeted Treatments
    • +

      OA03.05 - Tepotinib in Patients with MET Exon 14 (METex14) Skipping NSCLC: Primary Analysis of the Confirmatory VISION Cohort C

      14:52 - 15:02  |  Presenter: Michael Thomas

      • Abstract

      Loading...

  • +

    EP07.01 - Mesothelioma, Thymoma, and Other Thoracic Malignancies - Clinical

    • 09:45 - 18:00
    • 8/07/2022
    • Location: Exhibit Hall - Hall B
    • Not for CME Credit
    • Type: E-Poster
    • Track: Mesothelioma, Thymoma, and Other Thoracic Malignancies - Clinical
    • +

      EP07.01-022 - Analysis of Second Surgery for Recurrence in Malignant Pleural Mesothelioma (MPM) Patients (P)

      Presenter: Susana Cedres

      • Abstract

      Loading...

    • +

      EP07.01-023 - Family History of Cancer in a Series of Malignant Pleural Mesothelioma (MPM) Patients (P)

      Presenter: Susana Cedres

      • Abstract

      Loading...

  • +

    EP08.01 - Metastatic Non-small Cell Lung Cancer - Immunotherapy

    • 09:45 - 18:00
    • 8/07/2022
    • Location: Exhibit Hall - Hall B
    • Not for CME Credit
    • Type: E-Poster
    • Track: Metastatic Non-small Cell Lung Cancer - Immunotherapy
    • +

      EP08.01-078 - Clinical Outcomes in Metastatic Non-small Cell Lung Cancer Harboring BRAF Mutations Treated With Immune Checkpoint Inhibitors

      Presenter: Susana Cedres

      • Abstract

      Loading...

    • +

      EP08.01-109 - TACTI-002: A Phase II Study of Eftilagimod Alpha (Soluble LAG-3) & Pembrolizumab in 2nd line PD-1/PD-L1 Refractory Metastatic NSCLC

      Presenter: Martin Forster

      • Abstract

      Loading...

  • +

    EP08.02 - Metastatic Non-small Cell Lung Cancer - Molecular Targeted Treatments

    • 09:45 - 18:00
    • 8/07/2022
    • Location: Exhibit Hall - Hall B
    • Not for CME Credit
    • Type: E-Poster
    • Track: Metastatic Non-small Cell Lung Cancer - Molecular Targeted Treatments
    • +

      EP08.02-041 - NVL-520, a Highly Selective ROS1 Inhibitor, in Patients with Advanced ROS1-Positive Solid Tumors: The Phase 1/2 ARROS-1 Study

      Presenter: Alexander Drilon

      • Abstract

      Loading...

    • +

      EP08.02-081 - Cabozantinib Plus Atezolizumab in First or Second-Line Advanced NSCLC and Previously-Treated EGFR Mutant Advanced NSCLC

      Presenter: Joel W. Neal

      • Abstract

      Loading...

  • +

    EP16.03 - Tumor Biology and Biomarkers - Molecular Profiling and Targeted Therapeutics

    • 09:45 - 18:00
    • 8/07/2022
    • Location: Exhibit Hall - Hall B
    • Not for CME Credit
    • Type: E-Poster
    • Track: Tumor Biology and Biomarkers - Molecular Profiling and Targeted Therapeutics
    • +

      EP16.03-011 - The European Program for ROutine Testing of Patients with Advanced Lung Cancer (EPROPA) 1 Year Activity

      Presenter: Francesco Passiglia

      • Abstract

      Loading...

  • +

    P1.11 - Locally Advanced Non-small Cell Lung Cancer - Neoadjuvant and Adjuvant Therapy

    • 17:00 - 19:00
    • 8/07/2022
    • Location: Exhibit Hall - Hall B
    • Not for CME Credit
    • Type: Regular Poster
    • Track: Locally Advanced Non-small Cell Lung Cancer - Neoadjuvant and Adjuvant Therapy
    • +

      P1.11-01 - Cobolimab With Dostarlimab and Docetaxel in Patients With Advanced Non-small Cell Lung Cancer (NSCLC): COSTAR Lung

      Presenter: Hye Ryun Kim

      • Abstract

      Loading...

  • +

    PL03 - Plenary 3: Presidential Symposium - Top Rated Abstracts (Live Streamed Session)

    • 08:30 - 10:20
    • 8/08/2022
    • Location: Hall C1
    • IASLC CME Accredited
    • Type: Plenary
    • Track: N/A
    • +

      PL03.09 - IMpower010:Overall Survival Interim Analysis of a Phase III Study of Atezolizumab vs Best Supportive Care in Resected NSCLC

      Presenter: ENRIQUETA FELIP

      • Abstract

      Loading...

  • +

    P2.07 - Pathology - Tumour Genomics

    • 17:15 - 19:15
    • 8/08/2022
    • Location: Exhibit Hall - Hall B
    • Not for CME Credit
    • Type: Regular Poster
    • Track: Pathology - Tumour Genomics
    • +

      P2.07-02 - RET Fusion Testing with FISH and Real-Time PCR: a Comparison with RNA-Based Next-Generation Sequencing in RET Positive NSCLC

      Presenter: Susana Hernandez

      • Abstract

      Loading...